Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

India is the world's fastest improving pharma market: CPhI report

India is the world's fastest improving pharma market: CPhI report

2018-12-12

An industry report released on the eve of the mega pharma expo, CPhI India, has ranked India as the world’s fastest improving pharma market and first for ‘growth potential’ for 2019.

Aleor Dermaceuticals receives USFDA approval for Lidocaine Ointment

Aleor Dermaceuticals receives USFDA approval for Lidocaine Ointment

2018-12-12

Alembic Pharmaceuticals Ltd. has announced that its joint venture Aleor Dermaceuticals Ltd. has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Lidocaine Ointment USP, 5%.

Adents serialisation solution chosen by French pharma company to ensure  FMD

Adents serialisation solution chosen by French pharma company to ensure FMD

2018-12-11

Cloud solution enables Cristers to easily exchange serialisation data with supply chain partners and move beyond compliance to improve business practices

Evox Therapeutics to expand work on cell-targeted delivery of nucleic acid-based

Evox Therapeutics to expand work on cell-targeted delivery of nucleic acid-based

2018-12-11

Evox is engineering exosomes, the body’s natural vesicular delivery system, to enable a wide variety of drugs to reach previously inacce...

Avacta and LG Chem Life Sciences agree multitarget Affimer therapeutics

Avacta and LG Chem Life Sciences agree multitarget Affimer therapeutics

2018-12-11

Utilising Avacta’s Affimer technology – a novel non-antibody protein format overcoming limitations of classical antibody based therapy –...

GE Healthcare to open biotechnology manufacturing centre in UK

GE Healthcare to open biotechnology manufacturing centre in UK

2018-12-11

The company said the material that makes the fibre-based purification platform boasts a unique proprietary structure, which offers the p...

Lonza to establish strategic biomanufacturing base in China using GE Healthcare

Lonza to establish strategic biomanufacturing base in China using GE Healthcare

2018-12-11

Lonza announces an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (CN)

Swedish Biotage taps into US market with PhyNexus acquisition

Swedish Biotage taps into US market with PhyNexus acquisition

2018-12-11

Doug Gjerde, founder and CEO of PhyNexus, said: "PhyNexus has developed a unique, proprietary platform technology that delivers high thr...

Zydus receives USFDA approvals for atorvastatin calcium tablets

Zydus receives USFDA approvals for atorvastatin calcium tablets

2018-12-10

Lowering ‘bad’ cholesterol and triglycerides and raising ‘good’ cholesterol decreases the risk of heart disease and helps to prevent str...

Sun Pharma to acquire Pola Pharma in Japan

Sun Pharma to acquire Pola Pharma in Japan

2018-12-10

Pola Pharma is a leading dermatology company and it will help us to launch our speciality and generic dermatology products in the Japane...

New norms likely for drug distribution and storage

New norms likely for drug distribution and storage

2018-12-10

There have been several instances when popular medicines, including pain-killers, vitamins, antibiotics, anti-allergics have disintegrat...

Indoco's Goa Plant II & III clears USFDA inspection

Indoco's Goa Plant II & III clears USFDA inspection

2018-12-10

Indoco is committed to its philosophy of highest quality in manufacturing, operations, systems integrity and cGMP culture,” said Ms.

CII-PwC report: 77% Indian households use ayurvedic products

CII-PwC report: 77% Indian households use ayurvedic products

2018-12-10

The state is singularly advantaged in its ability to deliver ayurvedic products and services, in all segments of ayurveda, the report said.

AbbVie's Venclyxto combo beats standard of care in chronic lymphocytic leukaemia

AbbVie's Venclyxto combo beats standard of care in chronic lymphocytic leukaemia

2018-12-04

“The results of this analysis showed that a high proportion of patients with relapsed or refractory chronic lymphocytic leukaemia who we...

Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

Prevalence of Ever-Diagnosed ASD 2.79 Percent in U.S. Children

2018-12-04

The prevalence of ever-diagnosed autism spectrum disorder (ASD) is 2.79 percent in the United States, with state-level variations in prevalence, according to a study published online Dec. 3 in JAMA Pediatrics.

Novartis unveils strong longer-term Kymriah data at ASH 2018

Novartis unveils strong longer-term Kymriah data at ASH 2018

2018-12-04

"Before CAR-T cell therapy, achieving and maintaining a prolonged complete response in adult patients with relapsed or refractory DLBCL ...

Doctors More Cautious Now When Prescribing Opioids to Kids

Doctors More Cautious Now When Prescribing Opioids to Kids

2018-12-04

"Despite the downward trends for opioid prescriptions, the frequency of opioid use remains high given the risks associated with these me...

Rare Variants Associated With Interval Breast Cancers

Rare Variants Associated With Interval Breast Cancers

2018-12-04

Higher PRS was associated with less aggressive tumor characteristics (estrogen receptor-positive, progesterone receptor-positive, small ...

Astellas scores first US blood cancer approval with Xospata

Astellas scores first US blood cancer approval with Xospata

2018-12-03

“For the first time, people with relapsed or refractory FLT3 mutation-positive AML have an FDA approved FLT3 -targeting treatment availa...

ALS Organizations Collaborate to Advance New Therapeutic into Trials

ALS Organizations Collaborate to Advance New Therapeutic into Trials

2018-12-03

About Anelixis Therapeutics ALS TDI created Anelixis Therapeutics in 2012 as a for-profit clinical development subsidiary to develop AT-...

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message